ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41301018

Evaluating the Role of Morphological Subtypes in the Classification of Periampullary Adenocarcinomas.

Sancio JB and 9 others. Cancers (Basel), 2025. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Evaluating the Role of Morphological Subtypes in the Classification of Periampullary Adenocarcinomas. Papers, record 41301018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301018

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluating the Role of Morphological Subtypes in the Classification of Periampullary Adenocarcinomas.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-11-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sancio JBJoão Bernardohttps://orcid.org/0000-0001-8238-5095
2Ponte RVRaul Valériohttps://orcid.org/0009-0007-5424-3533
3Lima HAHenrique Araújohttps://orcid.org/0000-0002-3692-290X
4Marchiodi AHAugusto Henrique
5Yamashita YPHYuiti Pedro Henrique
6Lima LDPLeonardo do Pradohttps://orcid.org/0000-0002-8647-130X
7Souza PFLEPriscila Ferreira de Lima Ehttps://orcid.org/0000-0003-2777-3268
8Junior EPEduardo Paulinohttps://orcid.org/0000-0001-6157-6511
9Sanches MDMarcelo Diashttps://orcid.org/0000-0002-4430-8889
10Resende VVivianhttps://orcid.org/0000-0003-4400-0427

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,487,408Phase II study of gemcitabine in advanced colorectal adenocarcinoma.Invest New Drugs1992https://conductscience.org/library/papers/1487408PubMed
210,360,609Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer.Invest New Drugs1998https://conductscience.org/library/papers/10360609PubMed
327,556,536Cultural adaptation and the Clavien-Dindo surgical complications classification translated to Brazilian Portuguese.Rev Col Bras Cir2016https://conductscience.org/library/papers/27556536PubMed
410,361,177Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy.Br J Surg1999https://conductscience.org/library/papers/10361177PubMed
530,561,818Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.J Surg Oncol2019https://conductscience.org/library/papers/30561818PubMed
618,436,014The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer.Surgery2008https://conductscience.org/library/papers/18436014PubMed
738,353,072Prognostic value of nodal staging classification and number of examined lymph nodes among patients with ampullary cancer.J Gastrointest Surg2024https://conductscience.org/library/papers/38353072PubMed
827,732,711Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.JAMA Surg2017https://conductscience.org/library/papers/27732711PubMed
912,496,533Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.Ann Surg2003https://conductscience.org/library/papers/12496533PubMed
1019,476,786The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship.J Am Coll Surg2009https://conductscience.org/library/papers/19476786PubMed

1 to 10 of 31

See all 31 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301018

GET https://conductscience.org/api/papers/v1/41301018/references?page=2

API referenceFor AI assistants